PT3720428T - Composição tópica oftálmica compreendendo ácido dobesílico para tratamento de doenças do segmento posterior do olho - Google Patents

Composição tópica oftálmica compreendendo ácido dobesílico para tratamento de doenças do segmento posterior do olho

Info

Publication number
PT3720428T
PT3720428T PT188110233T PT18811023T PT3720428T PT 3720428 T PT3720428 T PT 3720428T PT 188110233 T PT188110233 T PT 188110233T PT 18811023 T PT18811023 T PT 18811023T PT 3720428 T PT3720428 T PT 3720428T
Authority
PT
Portugal
Prior art keywords
eye
treating diseases
topical composition
posterior segment
ophthalmic topical
Prior art date
Application number
PT188110233T
Other languages
English (en)
Original Assignee
Salvat Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salvat Lab Sa filed Critical Salvat Lab Sa
Publication of PT3720428T publication Critical patent/PT3720428T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT188110233T 2017-12-04 2018-11-29 Composição tópica oftálmica compreendendo ácido dobesílico para tratamento de doenças do segmento posterior do olho PT3720428T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382832 2017-12-04

Publications (1)

Publication Number Publication Date
PT3720428T true PT3720428T (pt) 2023-04-03

Family

ID=60673756

Family Applications (1)

Application Number Title Priority Date Filing Date
PT188110233T PT3720428T (pt) 2017-12-04 2018-11-29 Composição tópica oftálmica compreendendo ácido dobesílico para tratamento de doenças do segmento posterior do olho

Country Status (22)

Country Link
US (1) US20200390729A1 (pt)
EP (1) EP3720428B1 (pt)
JP (1) JP2021505554A (pt)
KR (1) KR20200096569A (pt)
CN (1) CN111542316A (pt)
BR (1) BR112020011160A2 (pt)
CA (1) CA3083835A1 (pt)
CL (1) CL2020001426A1 (pt)
DK (1) DK3720428T3 (pt)
ES (1) ES2941036T3 (pt)
FI (1) FI3720428T3 (pt)
HR (1) HRP20230319T1 (pt)
HU (1) HUE061852T2 (pt)
MA (1) MA50991B1 (pt)
MX (1) MX2020005809A (pt)
PH (1) PH12020550722A1 (pt)
PL (1) PL3720428T3 (pt)
PT (1) PT3720428T (pt)
SG (1) SG11202004940VA (pt)
SI (1) SI3720428T1 (pt)
WO (1) WO2019110416A1 (pt)
ZA (1) ZA202003944B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117257963B (zh) * 2023-11-02 2024-07-16 广州准优生物科技有限公司 含脐带间充质干细胞外泌体的眼用药剂及其制备方法和用途
CN117643573B (zh) * 2024-01-29 2024-05-03 天津医科大学眼科医院 一种可递送药物至眼后节的纳米滴眼液及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
US9198886B2 (en) * 2006-08-16 2015-12-01 Pedro Cuevas Sánchez Use of 2,5-dihydroxybenzene for the treatment of ocular diseases
AU2012344299A1 (en) * 2011-11-30 2014-05-29 Xigen Inflammation Ltd. Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of dry eye syndrome
ES2632012T3 (es) 2012-02-02 2017-09-07 Invesfovea S.L. Uso del ácido 2,5-dihidroxibenceno sulfonato para el tratamiento de la degeneración macular relacionada con la edad
ES2703324T3 (es) * 2012-03-05 2019-03-08 Univ Wayne State Identificación de mutaciones de canalrodopsina-2 (Chop2) y métodos de uso
AU2013254690B2 (en) * 2012-04-24 2017-12-07 Thrombogenics N.V. Anti-PDGF-C antibodies
EP2875811A1 (en) 2013-11-26 2015-05-27 Luis Antonio Outeirino Miguez Use of dobesilate for treating ocular haemorrhages

Also Published As

Publication number Publication date
CA3083835A1 (en) 2019-06-13
ES2941036T3 (es) 2023-05-16
CN111542316A (zh) 2020-08-14
KR20200096569A (ko) 2020-08-12
PH12020550722A1 (en) 2021-02-15
AU2018378981A1 (en) 2020-07-16
CL2020001426A1 (es) 2020-11-06
SG11202004940VA (en) 2020-06-29
BR112020011160A2 (pt) 2020-11-17
MA50991B1 (fr) 2023-03-31
ZA202003944B (en) 2022-12-21
HUE061852T2 (hu) 2023-08-28
JP2021505554A (ja) 2021-02-18
PL3720428T3 (pl) 2023-05-08
US20200390729A1 (en) 2020-12-17
WO2019110416A1 (en) 2019-06-13
DK3720428T3 (da) 2023-03-20
FI3720428T3 (fi) 2023-03-30
HRP20230319T1 (hr) 2023-05-12
MX2020005809A (es) 2020-08-20
EP3720428B1 (en) 2023-01-11
MA50991A (fr) 2020-10-14
SI3720428T1 (sl) 2023-05-31
EP3720428A1 (en) 2020-10-14

Similar Documents

Publication Publication Date Title
PT3399962T (pt) Composição oftálmica para o tratamento da doença do olho seco
IL277333A (en) Methods for treating eye diseases
EP3390634A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
IL281773A (en) Eye preparation for the treatment of dry eye disease
EP3515444A4 (en) COMPOSITION FOR TREATING EYE DISEASES AND METHOD FOR USE AND PRODUCTION
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
EP3481411A4 (en) TREATING GLAUCOMA AND OTHER EYE DISEASES
GB2541840B (en) Ophthalmic composition for the treatment of ocular infection
EP3713553A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF EYE DISEASES
ZA202002075B (en) Compounds, compositions and methods for treatment of eye disorders and skin diseases
EP3618868A4 (en) METHODS AND COMPOSITIONS FOR TREATING ALLERGIC EYE DISEASES
ZA202003944B (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
IL269698B (en) Methods for preventing or treating eye diseases
EP3265103A4 (en) Compositions and methods for treating ocular diseases
EP3643297A4 (en) OPHTHALMIC COMPOSITION FOR GLUCOMA TREATMENT
PL3515409T3 (pl) Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych
IL282898A (en) Ophthalmic compounds and methods for treating skin and eye diseases
PT3407879T (pt) Gabapentina oftálmica para o tratamento de úlceras da córnea
EP3402511A4 (en) COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES
IL280588A (en) Ophthalmic compositions and methods for treating eye problems and skin diseases
EP3310396A4 (en) THERAPEUTIC HYDROGELS BASED ON NANOFIBRES FOR THE LOCAL TREATMENT OF BRAIN DISEASES
PL3302463T3 (pl) Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu
IT201700099156A1 (it) Composizione oftalmica nanoparticellare per il trattamento di disturbi o patologie oculari
IL280952A (en) Methods and drug compounds for the treatment of ophthalmic diseases
EP3170500A4 (en) Prophylactic or therapeutic agent for diseases of posterior segment of eye